EnteroMedics (ETRM) Reports In-Line Q2 EPS

EnteroMedics (NASDAQ: ETRM) reported Q2 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $79 thousand versus the consensus estimate of $50 thousand.

For earnings history and earnings-related data on EnteroMedics (ETRM) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• CalPrivate Bank names Andra Frazier as chief credit officer
• Is Treasury selloff a major issue for stock market bulls?